| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $512.4M | -6.7% |
| Cost of Revenue | $62.7M | -73.8% |
| R&D Expense | $8.8M | +17.8% |
| SG&A Expense | $114.8M | -88.0% |
| Operating Income | $87.3M | +109.0% |
| Pre-tax Income | $102.7M | +110.8% |
| Income Tax | $1.5M | -36.8% |
| Net Income | $18.0M | +101.8% |
| EPS (Basic) | $0.73 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $158.6M | +14.0% |
| Accounts Receivable | $4.0M | -48.2% |
| Current Assets | $279.2M | +13.3% |
| Total Assets | $442.5M | +5.0% |
| Current Liabilities | $385.5M | -2.5% |
| Total Liabilities | $740.9M | -10.4% |
| Stockholders' Equity | -$21.2M | +56.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $48.4M | -24.0% |
| Capital Expenditures | $35K | -77.7% |
| Investing Cash Flow | -$13.2M | -59.3% |
| Financing Cash Flow | -$16.2M | +47.2% |
| Free Cash Flow | $48.3M | -23.8% |
| — |
| EPS (Diluted) | $0.73 | — |